Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  anorexia (loss of appetite)
Trial Type:  Supportive care
Trial Status:  Closed
Sponsor of Trial:  NCI
Results 1-12 of 12 for your search:
Start Over
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069218, NCCTG-989255, CAN-NCIC-SC18, NCI-P02-0205, SC18, NCT00031707
Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05)
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Adult
Sponsor: NCI, Other
Protocol IDs: CDR0000069417, NCCTG-N01C9, NCI-P02-0226, N01C9, NCT00040885
Phase III Trial of Nortriptyline in the Management of Pain, Sleep Disturbance, and Anorexia in Patients with Cancer
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-909258, MAYO-909258, NCI-P91-0014
Phase III Randomized Study of Megestrol Acetate vs Fluoxymesterone vs Dexamethasone for the Treatment of Cancer-Related and Cancer Treatment-Related Anorexia and Cachexia
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-919252, MAYO-919252, NCI-P92-0004
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000257027, NCCTG-N00C1, NCI-P02-0232, MC00C8, 1497-00, N00C1, NCT00046904
Creatine in Treating Patients With Cancer-Associated Weight Loss
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000360798, NCCTG-N02C4, N02C4, NCT00081250
Megestrol to Limit Weight Loss and Improve Quality of Life in Treating Patients With Head and Neck Cancer
Phase: Phase III
Type: Supportive care
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000068329, CCCWFU-97300, CCCWFU-0009, CCCWFU-BG00-228, NCI-P00-0174, NCT00006799
Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000069226, CCCWFU-98199, NCI-P02-0210, NCT00031785
Phase II Randomized Pilot Study of Pentoxifylline vs Placebo for Anorexia and Cachexia in Patients with Metastatic Malignancies (Summary Last Modified 03/98)
Phase: Phase II
Type: Supportive care
Status: Closed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-9327, NCI-P94-0058
Placebo-Controlled Evaluation of Megestrol Acetate in the Treatment of Cancer-Related Anorexia and Cachexia
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-889251, MAYO-889251
Dose-Response Evaluation of Megestrol to Treat Anorexia and Cachexia in Patients with Cancer
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-899255, MAYO-899255, NCI-P90-0009
Start Over